Impact of standardized Rhus verniciflua stokes extract as complementary therapy on metastatic colorectal cancer: A Korean single-center experience

Integrative Cancer Therapies

Volumn 8, Issue 2, 2009, Pages 148-152

  Lee, Sang Hun ^a   Choi, Won Cheol ^a   Yoon, Seong Woo ^b  

^a Kyung Hee University   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

Author keywords

Complementary and alternative medicine; Flavonoids; Metastatic colorectal cancer; Palliative care; Rhus verniciflua Stokes

Indexed keywords

ANTINEOPLASTIC AGENT; PLANT EXTRACT; RHUS VERNICIFLUA EXTRACT; UNCLASSIFIED DRUG;

ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; BLOOD TOXICITY; CANCER PATIENT; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DRUG DOSE REDUCTION; DYSPEPSIA; FEASIBILITY STUDY; FEMALE; HUMAN; KOREA; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; MEDICINAL PLANT; NONHUMAN; OVARY METASTASIS; OVERALL SURVIVAL; PERITONEUM METASTASIS; PRIORITY JOURNAL; PRURITUS; RHUS VERNICIFLUA; SURVIVAL RATE; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; COMPLEMENTARY THERAPIES; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; KOREA; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROPORTIONAL HAZARDS MODELS; RHUS; TREATMENT OUTCOME;

EID: 68949142782     PISSN: 15347354     EISSN: 1552695X     Source Type: Journal    
DOI: 10.1177/1534735409336438     Document Type: Article

References (18)

1. Bae JM, Won YJ, Jung KW, Park JG Annual report of the Korean central cancer registry program 2000. Cancer Res Treat. 2002 ; 34: 77-83.
2. Montemurro M., Achtari L., Röth A., et al. Systemic treatment of metastatic colorectal cancer. Rev Med Suisse. 2008 ; 4: 1254-1257.
3. Golfinopoulos V., Salanti G., Pavlidis N., Ioannidis JP Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysis. Lancet Oncol. 2007 ; 8: 898-911.
4. Jang HS, Kook SH, Son YO, et al. Flavonoids purified from Rhus verniciflua Stokes actively inhibit cell growth and induce apoptosis in human osteosarcoma cells. Biochim Biophys Acta. 2005 ; 1726: 309-316.
5. Son YO, Lee KY, Lee JC, et al. Selective antiproliferative and apoptotic effects of flavonoids purified from Rhus verniciflua Stokes on normal versus transformed hepatic cell lines. Toxicol Lett. 2005 ; 155: 115-125.
6. Bensky D., Gamble A., Kaptchuk T. Chinese Herbal Medicine: Materia Medica. Seattle, WA: Eastland Press; 1993.
7. Lee JC, Lee KY, Kim J., et al. Extract from Rhus verniciflua Stokes is capable of inhibiting the growth of human lymphoma cells. Food Chem Toxicol. 2004 ; 42: 1383-1388.
8. Samoszuk M., Tan J., Chorn G. The chalcone butein from Rhus verniciflua Stokes inhibits clonogenic growth of human breast cancer cells cocultured with fibroblasts. BMC Complement Altern Med. 2005 ; 5: 1-5.
9. Jeong JS, Park JW, Yoon SW, Choi WC Carcinostatic effect of allergen removed Rhus verniciflua Stokes based traditional Korean medicine on a patient with lung adenocarcinoma; single case report. OPEM. 2008 ; 5: 573-578.
10. Punt CJ, Buyse M., Köhne CH, et al. Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials. J Natl Cancer Inst. 2007 ; 99: 998-1003.
11. Rothenberg ML, Cox JV, Butts C., et al. Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study. Ann Oncol. 2008 ; 19: 1720-1726.
12. Cohen MH, Gootenberg J., Keegan P., Pazdur R. FDA drug approval summary: bevacizumab plus FOLFOX4 as second-line treatment of colorectal cancer. Oncologist. 2007 ; 12: 356-361.
13. Gundgaard MG, Soerensen JB, Ehrnrooth E. Third-line therapy for metastatic colorectal cancer. Cancer Chemother Pharmacol. 2008 ; 61: 1-13.
14. Choi WC, Lee JH, Lee EO, et al. Study on antiangiogenic and antitumor activities of processed Rhus verniciflua Stokes extract. Korean J Oriental Physiology & Pathology. 2006 ; 20: 825-829.
15. Choi WC, Sminova Z., Kubasova I., Baryshnikov A. Antitumor efficacy of the allergen-removed extract (ACM909Q) in Rhus verniciflua. Eur J Pharm Sci. 2002 ; 17S: 78-79.
16. Kook SH, Son YO, Chung SW, et al. Caspase-independent death of human osteosarcoma cells by flavonoids is driven by p53-mediated mitochondrial stress and nuclear translocation of AIF and endonuclease G. Apoptosis. 2007 ; 12: 1289-1298.
17. Kim JH, Go HY, Jin DH, et al. Inhibition of the PI3K-Akt/PKB survival pathway enhanced an ethanol extract of Rhus verniciflua Stokes-induced apoptosis via a mitochondrial pathway in AGS gastric cancer cell lines. Cancer Lett. 2008 ; 265: 197-205.
18. Lee JH, Lee HJ, Lee HJ, et al. Rhus verniciflua Stokes prevents cisplatin-induced cytotoxicity and reactive oxygen species production in MDCK-I renal cells and intact mice. Phytomedicine. 2009 ; 16: 188-197.